These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7159481

  • 1. Monoamine oxidase type A: differences in selectivity towards l-norepinephrine compared to serotonin.
    Garrick NA, Murphy DL.
    Biochem Pharmacol; 1982 Dec 15; 31(24):4061-6. PubMed ID: 7159481
    [Abstract] [Full Text] [Related]

  • 2. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA, Zagorevskiĭ VA, Lopatina KI, Sokolova TV, Gankina EM.
    Biull Eksp Biol Med; 1986 Aug 15; 102(8):170-2. PubMed ID: 3742029
    [Abstract] [Full Text] [Related]

  • 3. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P, Cavalier R, David-Remacle M, Youdim MB.
    J Neurochem; 1988 Apr 15; 50(4):1011-6. PubMed ID: 3346666
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys.
    Garrick NA, Scheinin M, Chang WH, Linnoila M, Murphy DL.
    Biochem Pharmacol; 1984 May 01; 33(9):1423-7. PubMed ID: 6203542
    [Abstract] [Full Text] [Related]

  • 5. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
    Garrick NA, Murphy DL.
    Psychopharmacology (Berl); 1980 May 01; 72(1):27-33. PubMed ID: 6781004
    [No Abstract] [Full Text] [Related]

  • 6. Styrene inhibits monoamine oxidase A, but not monoamine oxidase B in monkey brain mitochondria.
    Egashira T, Takayama F, Sakai K, Yamanaka Y.
    Toxicol Lett; 2000 Sep 30; 117(1-2):115-9. PubMed ID: 11033241
    [Abstract] [Full Text] [Related]

  • 7. Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain.
    Fowler CJ, Tipton KF.
    J Neurochem; 1982 Mar 30; 38(3):733-6. PubMed ID: 7057191
    [Abstract] [Full Text] [Related]

  • 8. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL, Garrick NA, Aulakh CS, Cohen RM.
    J Clin Psychiatry; 1984 Jul 30; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [Abstract] [Full Text] [Related]

  • 9. Golden hamster pancreatic islets: a tissue rich in monoamine oxidase.
    Feldman JM, White-Owen C, Klatt C.
    Endocrinology; 1980 Nov 30; 107(5):1504-11. PubMed ID: 7000496
    [Abstract] [Full Text] [Related]

  • 10. Monoamine oxidase in bovine thyroid tissue.
    Masini-Repiso AM, Cabanillas AM, Andrada MC, Coleoni AH.
    Horm Metab Res; 1986 Nov 30; 18(11):750-3. PubMed ID: 3098663
    [Abstract] [Full Text] [Related]

  • 11. Modification of substrate-inhibitor affinities of human platelet monoamine oxidase B in vitro.
    Szutowicz A, Tomaszewicz M, Orsulak PJ.
    J Biol Chem; 1989 Oct 25; 264(30):17660-4. PubMed ID: 2509446
    [Abstract] [Full Text] [Related]

  • 12. [Properties of intestinal monoamine oxidase in the rat].
    Verevkina IV, Asnina VV, Gorkin VZ.
    Vopr Med Khim; 1982 Oct 25; 28(2):88-93. PubMed ID: 7080482
    [Abstract] [Full Text] [Related]

  • 13. Brain region differences and some characteristics of monoamine oxidase type A and B activities in the vervet monkey.
    Murphy DL, Redmond DE, Garrick N, Baulu J.
    Neurochem Res; 1979 Feb 25; 4(1):53-62. PubMed ID: 109783
    [Abstract] [Full Text] [Related]

  • 14. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine.
    Kitaichi Y, Inoue T, Nakagawa S, Boku S, Izumi T, Koyama T.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):77-82. PubMed ID: 20406628
    [Abstract] [Full Text] [Related]

  • 15. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
    Ask AL, Hellström W, Norrman S, Ogren SO, Ross SB.
    Neuropharmacology; 1982 Apr 10; 21(4):299-308. PubMed ID: 7088264
    [Abstract] [Full Text] [Related]

  • 16. Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase.
    Koide Y, Kobayashi K.
    Neurochem Res; 1984 May 10; 9(5):595-606. PubMed ID: 6472564
    [Abstract] [Full Text] [Related]

  • 17. Beta-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: A source of some anomalies?
    Lewinsohn R, Glover V, Sandler M.
    Biochem Pharmacol; 1980 Mar 01; 29(5):777-81. PubMed ID: 20227955
    [Abstract] [Full Text] [Related]

  • 18. In vivo, noradrenaline is a substrate for rat brain monoamine oxidase A and B.
    Youdim MB.
    Br J Pharmacol; 1983 Jun 01; 79(2):477-80. PubMed ID: 6652339
    [Abstract] [Full Text] [Related]

  • 19. Some interrelated properties of A and B form monoamine oxidase in monkey brain mitochondria.
    Egashira T, Yamamoto T, Yamanaka Y.
    Jpn J Pharmacol; 1984 Mar 01; 34(3):327-34. PubMed ID: 6427500
    [Abstract] [Full Text] [Related]

  • 20. Phenethylamine is a substrate of monoamine oxidase B in the paraventricular thalamic nucleus.
    Obata Y, Kubota-Sakashita M, Kasahara T, Mizuno M, Nemoto T, Kato T.
    Sci Rep; 2022 Jan 07; 12(1):17. PubMed ID: 34996979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.